Chest
EditorialsBronchiectasis in Patients With COPD: A Distinct COPD Phenotype?
References (13)
Bronchiectasis
Chest
(2008)- et al.
Factors associated with bronchiectasis in patients with COPD
Chest
(2011) - et al.
The role of CT scanning in multidimensional phenotyping of COPD
Chest
(2011) Does coexistence with bronchiectasis influence intensive care unit outcome in patients with chronic obstructive pulmonary disease?
Heart Lung
(2006)- et al.
The chronic bronchitic phenotype of COPD: an analysis of the COPDGene study
Chest
(2011) Bronchiectasis
N Engl J Med
(2002)
Cited by (23)
Mortality in non-cystic fibrosis bronchiectasis: A prospective cohort analysis
2014, Respiratory MedicineCitation Excerpt :Whether COPD associated bronchiectasis is a distinct COPD phenotype, cannot be concluded from our study as we did not compare COPD patients without bronchiectasis. However, our data add to previous research suggesting that COPD with bronchiectasis is different from bronchiectasis in other circumstances [19–21]. The higher mortality might be attributed to the fact that these patients have more severe and more frequent exacerbations, higher degree of airway inflammation, lower lung function and increased colonization [19,22,23].
Validity and reliability of the St. George's respiratory questionnaire in assessing health status in patients with chronic pulmonary aspergillosis
2013, ChestCitation Excerpt :This study showed that COPD was the most common and effective underlying comorbidity with CPA. Since both CPA1,2,5 and COPD34–36 are chronic, progressive, inflammatory, pulmonary diseases, a possibility of an existing interaction between these two diseases can be suggested. Perhaps “synergistic” destruction of pulmonary tissue and inflammation would contribute to the high SGRQ score of those who had both diseases.
Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease
2023, Frontiers in ImmunologyBronchiectasis associated with chronic obstructive pulmonary disease: clinical and evolutionary profile
2020, Pan African Medical JournalImpact of radiographic bronchiectasis in copd
2020, Respiratory Care
Financial/nonfinancial disclosures: The author has reported to CHEST the following conflicts of interest: Dr O'Donnell has received research funding for clinical trials from Bronchiectasis Registry/COPD Foundation; Gilead Sciences, Inc; Bayer Corporation; Pharmaxis, Inc; and Insmed Incorporated. She has received consultant fees from Gilead Sciences, Inc; Bayer Corporation; and Hill-Rom, Inc.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).